IL87778A - Topical pharmaceutical compositions in the form of a hydrogel containing stabilized therapeutically active proteins and their preparation - Google Patents
Topical pharmaceutical compositions in the form of a hydrogel containing stabilized therapeutically active proteins and their preparationInfo
- Publication number
- IL87778A IL87778A IL87778A IL8777888A IL87778A IL 87778 A IL87778 A IL 87778A IL 87778 A IL87778 A IL 87778A IL 8777888 A IL8777888 A IL 8777888A IL 87778 A IL87778 A IL 87778A
- Authority
- IL
- Israel
- Prior art keywords
- therapeutically active
- preparation
- pharmaceutical compositions
- active proteins
- topical pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Abstract
The pharmaceutical preparations are for topical use, contain one or more stabilised therapeutically active proteins and, where appropriate, customary auxiliaries, vehicles and additives, and are prepared as described using physiologically tolerated hydrophobic substances for stabilising proteins.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19873731255 DE3731255A1 (en) | 1987-09-17 | 1987-09-17 | Stabilization of therapeutically active proteins in pharmaceutical preparations |
Publications (2)
Publication Number | Publication Date |
---|---|
IL87778A0 IL87778A0 (en) | 1989-03-31 |
IL87778A true IL87778A (en) | 1993-05-13 |
Family
ID=6336244
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL87778A IL87778A (en) | 1987-09-17 | 1988-09-16 | Topical pharmaceutical compositions in the form of a hydrogel containing stabilized therapeutically active proteins and their preparation |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0307857B1 (en) |
JP (1) | JP2783552B2 (en) |
KR (1) | KR970008112B1 (en) |
AT (1) | ATE126063T1 (en) |
AU (1) | AU615473B2 (en) |
CA (1) | CA1329121C (en) |
DD (1) | DD274562A5 (en) |
DE (2) | DE3731255A1 (en) |
DK (1) | DK516288A (en) |
ES (1) | ES2077559T3 (en) |
FI (1) | FI95770C (en) |
GR (1) | GR3017432T3 (en) |
HU (1) | HU203045B (en) |
IE (1) | IE70908B1 (en) |
IL (1) | IL87778A (en) |
NO (1) | NO179436C (en) |
NZ (1) | NZ226209A (en) |
PT (1) | PT88539B (en) |
RU (1) | RU2093145C1 (en) |
ZA (1) | ZA886903B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5332577A (en) * | 1988-12-27 | 1994-07-26 | Dermamed | Transdermal administration to humans and animals |
US5241925A (en) * | 1988-12-27 | 1993-09-07 | Dermamed | Apparatus and techniques for administering veterinary medicaments |
US5130298A (en) * | 1989-05-16 | 1992-07-14 | Ethicon, Inc. | Stabilized compositions containing epidermal growth factor |
US5324521A (en) * | 1989-12-18 | 1994-06-28 | Dermamed | Systems for transdermal administration of medicaments |
JPH0776527A (en) * | 1993-06-28 | 1995-03-20 | Hayashibara Biochem Lab Inc | Semi-solid preparation and production thereof |
ITMI20031640A1 (en) * | 2003-08-08 | 2005-02-09 | Mipharm S P A | BASE FOR BIOADHESIVE GEL. |
CU23432B6 (en) * | 2005-11-02 | 2009-10-16 | Ct Ingenieria Genetica Biotech | STABILIZED FORMULATIONS CONTAINING GAMMA AND ALFA INTERFERONS IN POTENTIAL PROPORTIONS |
ES2454776T3 (en) * | 2010-05-04 | 2014-04-11 | Viscogel Ab | Chitosan composition |
BR122021011439B1 (en) * | 2017-06-12 | 2022-03-29 | Lakewood Amedex, Inc | Bisphosphocine gel formulation and uses |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5413223A (en) * | 1977-07-01 | 1979-01-31 | Ricoh Co Ltd | Printer unit |
GB2016015B (en) * | 1978-01-22 | 1982-05-06 | Hayashibara Co | Method of preparing interferon and preparations containing interferon |
JPS5598118A (en) * | 1979-01-18 | 1980-07-25 | Hayashibara Takeshi | Preparation of type-2 interferon and drug containing the same |
FR2513124B1 (en) * | 1981-07-21 | 1989-11-17 | Hayashibara Biochem Lab | PRODUCTION AND APPLICATIONS OF THE TARGET CELL LYSE FACTOR |
CA1190148A (en) * | 1981-10-13 | 1985-07-09 | Samuel S. Asculai | Interferon-containing compositions |
JPS5892622A (en) * | 1981-11-28 | 1983-06-02 | Sunstar Inc | Pharmaceutical preparation containing stably compounded interferon |
US4659696A (en) * | 1982-04-30 | 1987-04-21 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition and its nasal or vaginal use |
JPS5910524A (en) * | 1982-07-08 | 1984-01-20 | Toray Ind Inc | Interferon composition and its preparation |
JPS6061535A (en) * | 1983-08-24 | 1985-04-09 | エフ・ホフマン・ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト | Pharmaceutical composition |
EP0177342A3 (en) * | 1984-10-04 | 1987-12-02 | Genentech, Inc. | Oral formulation of therapeutic proteins |
DE3603444A1 (en) * | 1986-02-05 | 1987-08-06 | Thomae Gmbh Dr K | PHARMACEUTICAL PREPARATIONS FOR STABILIZING INTERFERON ALPHA |
US4822605A (en) * | 1986-02-18 | 1989-04-18 | Exovir, Inc. | Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like |
-
1987
- 1987-09-17 DE DE19873731255 patent/DE3731255A1/en not_active Ceased
-
1988
- 1988-09-13 AT AT88114944T patent/ATE126063T1/en not_active IP Right Cessation
- 1988-09-13 EP EP88114944A patent/EP0307857B1/en not_active Expired - Lifetime
- 1988-09-13 DE DE3854290T patent/DE3854290D1/en not_active Expired - Lifetime
- 1988-09-13 ES ES88114944T patent/ES2077559T3/en not_active Expired - Lifetime
- 1988-09-15 FI FI884240A patent/FI95770C/en not_active IP Right Cessation
- 1988-09-16 IL IL87778A patent/IL87778A/en active Protection Beyond IP Right Term
- 1988-09-16 NZ NZ226209A patent/NZ226209A/en unknown
- 1988-09-16 CA CA000577614A patent/CA1329121C/en not_active Expired - Lifetime
- 1988-09-16 IE IE281288A patent/IE70908B1/en not_active IP Right Cessation
- 1988-09-16 DD DD88319876A patent/DD274562A5/en not_active IP Right Cessation
- 1988-09-16 HU HU884894A patent/HU203045B/en unknown
- 1988-09-16 NO NO884123A patent/NO179436C/en not_active IP Right Cessation
- 1988-09-16 JP JP63232113A patent/JP2783552B2/en not_active Expired - Lifetime
- 1988-09-16 ZA ZA886903A patent/ZA886903B/en unknown
- 1988-09-16 AU AU22316/88A patent/AU615473B2/en not_active Expired
- 1988-09-16 DK DK516288A patent/DK516288A/en not_active Application Discontinuation
- 1988-09-16 KR KR1019880011951A patent/KR970008112B1/en not_active IP Right Cessation
- 1988-09-16 PT PT88539A patent/PT88539B/en not_active IP Right Cessation
-
1992
- 1992-04-24 RU SU925011455A patent/RU2093145C1/en active
-
1995
- 1995-09-18 GR GR950402557T patent/GR3017432T3/en unknown
Also Published As
Publication number | Publication date |
---|---|
PT88539A (en) | 1988-10-01 |
JP2783552B2 (en) | 1998-08-06 |
NO884123L (en) | 1989-03-20 |
ES2077559T3 (en) | 1995-12-01 |
FI95770B (en) | 1995-12-15 |
KR890004719A (en) | 1989-05-09 |
EP0307857B1 (en) | 1995-08-09 |
RU2093145C1 (en) | 1997-10-20 |
ATE126063T1 (en) | 1995-08-15 |
KR970008112B1 (en) | 1997-05-21 |
JPH01102029A (en) | 1989-04-19 |
DK516288A (en) | 1989-03-18 |
FI884240A (en) | 1989-03-18 |
GR3017432T3 (en) | 1995-12-31 |
DK516288D0 (en) | 1988-09-16 |
ZA886903B (en) | 1990-05-30 |
AU2231688A (en) | 1989-03-23 |
AU615473B2 (en) | 1991-10-03 |
DE3854290D1 (en) | 1995-09-14 |
NO179436C (en) | 1996-10-09 |
DE3731255A1 (en) | 1989-04-06 |
IL87778A0 (en) | 1989-03-31 |
EP0307857A1 (en) | 1989-03-22 |
FI884240A0 (en) | 1988-09-15 |
PT88539B (en) | 1992-11-30 |
IE882812L (en) | 1989-03-17 |
NO884123D0 (en) | 1988-09-16 |
HU203045B (en) | 1991-05-28 |
IE70908B1 (en) | 1997-01-15 |
FI95770C (en) | 1996-03-25 |
DD274562A5 (en) | 1989-12-27 |
NO179436B (en) | 1996-07-01 |
CA1329121C (en) | 1994-05-03 |
NZ226209A (en) | 1991-06-25 |
HUT47436A (en) | 1989-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK160995A (en) | Complex compounds of bioflavonoids with phospholipids their preparation and use and pharmaceutical and cosmetic compositions containing them | |
IL91343A0 (en) | Anti-neoplastic combination preparations | |
ZA885192B (en) | Pharmaceutical preparations | |
EP0283713A3 (en) | Complexes of saponins with phospholipids and pharmaceutical and cosmetic compositions containing them | |
CA2005143A1 (en) | Stabilized hydrophobic protein formulations of g-csf | |
AU1099288A (en) | Drug delivery system and method of making the same | |
DK642587A (en) | INSULIN PREPARATION | |
PT97160A (en) | Process for the preparation of stable compositions for parenteral administration containing a biologically active protein, polypeptide or polypeptide | |
EP0177342A3 (en) | Oral formulation of therapeutic proteins | |
IL87778A (en) | Topical pharmaceutical compositions in the form of a hydrogel containing stabilized therapeutically active proteins and their preparation | |
TW290455B (en) | ||
PT996462E (en) | PREPARATIONS OF PHARMACEUTICAL COMBINATIONS CONTAINING ERYTHROPOIETIN AND MODIFIED HEMOGLOBINS | |
AU1518492A (en) | Pharmaceutical compositions for transcutaneous administration | |
AU4150489A (en) | Micronised drug formulation | |
AU536582B2 (en) | Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends | |
IL85651A0 (en) | Optically active oxo-isoindolinyl derivatives,their preparation and pharmaceutical compositions containing them | |
EP0265338A3 (en) | Stable therapeutical compositions based on hydrophobic vegetable oil, and process for preparing them | |
AU2506188A (en) | Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance | |
GR3032639T3 (en) | Vehicles for oral adminstration of pharmaceutically active acide labile substances. | |
IL81926A0 (en) | Pharmaceutical compositions for the oral administration of active proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
EXTN | Extension order renewed |